HUP0102815A3 - New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it - Google Patents
New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing itInfo
- Publication number
- HUP0102815A3 HUP0102815A3 HU0102815A HUP0102815A HUP0102815A3 HU P0102815 A3 HUP0102815 A3 HU P0102815A3 HU 0102815 A HU0102815 A HU 0102815A HU P0102815 A HUP0102815 A HU P0102815A HU P0102815 A3 HUP0102815 A3 HU P0102815A3
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- pharmaceutical compositions
- crystalline form
- compositions containing
- butylamine salt
- Prior art date
Links
- IYNMDWMQHSMDDE-MHXJNQAMSA-N perindopril erbumine Chemical class CC(C)(C)N.C1CCC[C@@H]2N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H](C(O)=O)C[C@@H]21 IYNMDWMQHSMDDE-MHXJNQAMSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0102815A HU225340B1 (en) | 2000-07-06 | 2001-07-05 | New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0008793A FR2811320B1 (en) | 2000-07-06 | 2000-07-06 | NOVEL ALPHA CRYSTALLINE FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRIL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
HU0102815A HU225340B1 (en) | 2000-07-06 | 2001-07-05 | New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it |
Publications (4)
Publication Number | Publication Date |
---|---|
HU0102815D0 HU0102815D0 (en) | 2001-09-28 |
HUP0102815A2 HUP0102815A2 (en) | 2002-02-28 |
HUP0102815A3 true HUP0102815A3 (en) | 2003-12-29 |
HU225340B1 HU225340B1 (en) | 2006-09-28 |
Family
ID=89979493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0102815A HU225340B1 (en) | 2000-07-06 | 2001-07-05 | New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it |
Country Status (1)
Country | Link |
---|---|
HU (1) | HU225340B1 (en) |
-
2001
- 2001-07-05 HU HU0102815A patent/HU225340B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUP0102815A2 (en) | 2002-02-28 |
HU225340B1 (en) | 2006-09-28 |
HU0102815D0 (en) | 2001-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU0102814D0 (en) | New gamma crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it | |
HU0102813D0 (en) | New betha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it | |
HUP0301351A3 (en) | Use of substituted dipeptides as growth hormone secretagogues, process for their preparation and pharmaceutical compositions containing them | |
AU2001276420A1 (en) | Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. | |
AU7641801A (en) | Alpha crystalline form of perindopril tert-butylamine salt | |
HUP0302519A3 (en) | Crystalline forms of atorvastatin, process for their preparation and pharmaceutical compositions containing them | |
HUP0400927A3 (en) | New crystalline form and pure modafinil, process of preparing them, and pharmaceutical compositions containing the new crystalline form | |
HUP0200190A2 (en) | Dimeric compounds and as inhibitors of neuraminidase, process for their preparation and pharmaceutical compositions containing them | |
HUP0300148A3 (en) | Dipeptide nitrile cathepsin k inhibitors, process for their preparation and pharmaceutical compositions containing them | |
PL396568A1 (en) | Crystalline O-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline O-desmethyl-venlafaxine succinate | |
HUP0401141A3 (en) | Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them | |
HUP0102723A3 (en) | New diphenylurea derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0201909A3 (en) | Aminobenzophenones as inhibitors of il-1betha and tnf-alpha, process for producing them and pharmaceutical compositions containing them | |
HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
HUP0401499A3 (en) | Indole derivatives as cox ii inhibitors, process for their preparation and pharmaceutical compositions containing them | |
HUP0402391A3 (en) | Crystalline sodium salt of telmisartan, process for its production and pharmaceutical compositions containing it | |
HUP0300389A3 (en) | Crystalline form ii of cabergoline, process for its preparation and pharmaceutical compositions containing it | |
HUP0300231A3 (en) | Process for the preparation of high purity perindopril and intermediates useful in the synthesis, pharmaceutical compositions containing the compound and their use | |
HUP0204005A3 (en) | Novel forms of pravastatin sodium, process for their preparation and pharmaceutical compositions containing them | |
HUP0200913A3 (en) | Isoindoindololone derivatives process for their preparation and pharmaceutical compositions containing them | |
HU0102815D0 (en) | New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it | |
HUP0402283A3 (en) | Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them | |
HUP0401912A3 (en) | Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them | |
SI1266887T1 (en) | Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them | |
HU1000441D0 (en) | Substituted alkylpyridazone derivatives, process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: LES LABORATOIRES SERVIER, FR Free format text: FORMER OWNER(S): ADIR ET COMPAGNIE, FR |
|
MH4A | Lapse of definitive patent protection due to relinquishment | ||
MC4A | Revocation of the patent |